Technical Analysis for AQS - Aequus Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade C 0.13 0.00% 0.000
AQS closed unchanged on Tuesday, February 18, 2020, on 6 percent of normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down
Historical AQS trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Fell Below 20 DMA Bearish 4.00%
Fell Below 50 DMA Bearish 4.00%
MACD Bearish Signal Line Cross Bearish 4.00%
Wide Bands Range Expansion 4.00%
20 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%
Hammer Candlestick Bullish 0.00%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Aequus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products. The Company operates through the segment of sales and marketing of pharmaceutical drugs developed by the Company or by its collaborative partners. Its products include tacrolimus immediate releaser, which is an immunosuppressive therapy used for the treatment and prevention of acute rejection following organ transplantation; Vistitan, which is a ophthalmology product; Topiramate extended-release (XR), which is a once-daily topiramate product designed for patient compliance, and Oxcarbazepine XR, which is a once-daily oxcarbazepine product. Its development-stage pipeline includes various products in neurology and psychiatry. Its lead development-stage product candidate is AQS-1301. In addition, the Company is developing a pipeline of other central nervous system product candidates. It has over two preclinical-stage programs and a clinical-stage program in development.
Chemistry Medicine Pharmaceutical Neurochemistry Anticonvulsants Transplantation

Is AQS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.245
52 Week Low 0.09
Average Volume 96,641
200-Day Moving Average 0.149
50-Day Moving Average 0.127
20-Day Moving Average 0.134
10-Day Moving Average 0.133
Average True Range 0.009
ADX 17.79
+DI 20.065
-DI 27.913
Chandelier Exit (Long, 3 ATRs ) 0.113
Chandelier Exit (Short, 3 ATRs ) 0.122
Upper Bollinger Band 0.146
Lower Bollinger Band 0.121
Percent B (%b) 0.36
BandWidth 18.427
MACD Line 0.002
MACD Signal Line 0.002
MACD Histogram -0.0007
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.138
Resistance 3 (R3) 0.137 0.133 0.136
Resistance 2 (R2) 0.133 0.131 0.134 0.136
Resistance 1 (R1) 0.132 0.130 0.133 0.133 0.135
Pivot Point 0.128 0.128 0.129 0.129 0.128
Support 1 (S1) 0.127 0.126 0.128 0.128 0.125
Support 2 (S2) 0.123 0.125 0.124 0.124
Support 3 (S3) 0.122 0.123 0.124
Support 4 (S4) 0.123